2004
DOI: 10.1016/j.peptides.2003.12.022
|View full text |Cite
|
Sign up to set email alerts
|

Synergistic effects of systemic trefoil factor family 1 (TFF1) peptide and epidermal growth factor in a rat model of colitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
28
0
1

Year Published

2005
2005
2014
2014

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(33 citation statements)
references
References 29 publications
4
28
0
1
Order By: Relevance
“…Indeed, Poulsen et al found that while oral treatment with hTFF2 or hTFF3 ameliorated disease, subcutaneous treatment increased the disease score, in agreement with the previous finding by this author that subcutaneous hTFF2 aggravated duodenal ulcers [167]. This led to the suggestion that the markedly lower doses used in [169] may stimulate migration and healing but not affect the viscoelastic properties of mucus, which could potentially have negative effects in the colitis models. Accordingly, we have shown that systemically administered TFF2 and TFF3 specifically binds to cells in the stomach and are transported to the lumen, and that high doses (5 -25 mg/kg) of TFF2 enhance the viscosity of the gastric mucus [158,172,173].…”
Section: Effect Of Tffs In Animal Models Of Diseasesupporting
confidence: 65%
See 1 more Smart Citation
“…Indeed, Poulsen et al found that while oral treatment with hTFF2 or hTFF3 ameliorated disease, subcutaneous treatment increased the disease score, in agreement with the previous finding by this author that subcutaneous hTFF2 aggravated duodenal ulcers [167]. This led to the suggestion that the markedly lower doses used in [169] may stimulate migration and healing but not affect the viscoelastic properties of mucus, which could potentially have negative effects in the colitis models. Accordingly, we have shown that systemically administered TFF2 and TFF3 specifically binds to cells in the stomach and are transported to the lumen, and that high doses (5 -25 mg/kg) of TFF2 enhance the viscosity of the gastric mucus [158,172,173].…”
Section: Effect Of Tffs In Animal Models Of Diseasesupporting
confidence: 65%
“…As long as the TFFs in vivo mode of action is unclear, the optimal administration route cannot be determined. As in gastric ulceration models, there was a synergistic effect of hTFF1 and EGF [169], and dimeric hTFF1 and hTFF3 were superior to the monomers [164,171]. A marked and equally potent effect of all three trefoils was seen in the DSS model, when the trefoils were expressed locally in the colon by genetically engineered orally administered Lactococcus lactis [174].…”
Section: Effect Of Tffs In Animal Models Of Diseasementioning
confidence: 91%
“…Combined TFF3 and EGF act synergistically with respect to their protective/ motogenic effects in in vivo and in vitro wound healing models [45]. Similar effects were reported for TFF1 and TFF2 pointing again to a natural synergy of TFFs and EGF [35,44,46].…”
Section: Introductionsupporting
confidence: 55%
“…However, the regulation of postnatal intestinal development is known to be influenced by multiple factors modulating intestinal growth, which are also associated with TFF signaling pathways [16,50,51]. Therefore, our following results add additional information to the functional intestinal cellular network that is part of a TFFmediated response.…”
Section: Discussionmentioning
confidence: 65%